Search

Search any products, services and so on here.

About 16311 result(s)

Global Sotalol Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3135
  • Pages: 85
  • Figures: 189
  • Views: 30
  • From $2,900

Sotalol is a medication used to treat abnormal heart rhythms. The global Sotalol Drug market was valued at US$ 601 million in 2023 and is anticipated to reach US$ 869.6 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes...


Global Diltiazem Market Research Report 2024

  • Jan 18, 24
  • ID: 3136
  • Pages: 89
  • Figures: 214
  • Views: 33
  • From $2,900

Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, stre...


Global Fluvastatin Sodium Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3137
  • Pages: 73
  • Figures: 151
  • Views: 19
  • From $2,900

Fluvastatin is a member of the statin drug class, used to treat hypercholesterolemia and to prevent cardiovascular disease. The global Fluvastatin Sodium Drug market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 186.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a...


Global Telmisartan and Hydrochlorothiazide Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3138
  • Pages: 89
  • Figures: 202
  • Views: 19
  • From $2,900

Telmisartan and Hydrochlorothiazide Drug is a combination product that contains two medications used to lower hypertension (high blood pressure): telmisartan and hydrochlorothiazide. It is used to treat high blood pressure for people who require treatment with both telmisartan and hydrochlorothiazide. The global Telmisartan and Hydrochlorothiazide Drug market was valued at US$ 547 million in 2023...


Global Nitroglycerin for Angina Market Research Report 2024

  • Jan 18, 24
  • ID: 3139
  • Pages: 77
  • Figures: 185
  • Views: 17
  • From $2,900

Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. The global Nitroglycerin for Angina market was valued at US$ 324 million in 2023 and is anticipated to reach US$ 505.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 202...


Global Terbinafine Hydrochloride Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3140
  • Pages: 103
  • Figures: 231
  • Views: 19
  • From $2,900

Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections. The global Terbinafine Hydrochloride Drug market was valued at...


Global Tacrolimus Ointment Market Research Report 2024

  • Jan 18, 24
  • ID: 3141
  • Pages: 80
  • Figures: 180
  • Views: 19
  • From $2,900

Tacrolimus ointment is a topical drug (a drug that is applied to the skin) that is used for the treatment of atopic dermatitis (eczema). Atopic dermatitis is a chronic (long-lasting) disease of skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. The inflammation is caused by activation of the immune system though the reason for t...


Global Cetrotide Market Research Report 2024

  • Jan 18, 24
  • ID: 3142
  • Pages: 68
  • Figures: 160
  • Views: 17
  • From $2,900

Cetrotide is a medication known as a gonadotropin-releasing hormone antagonist and is used to prevent premature ovulation in women undergoing fertility procedures. The global Cetrotide market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 233.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. North American market for Cetrotide is estimated...


Global Clindamycin Phosphate Topical Market Research Report 2024

  • Jan 18, 24
  • ID: 3143
  • Pages: 79
  • Figures: 185
  • Views: 20
  • From $2,900

Clindamycin Phosphate Topical, USP 1% is indicated in the treatment of acne vulgaris. The global Clindamycin Phosphate Topical market was valued at US$ 224 million in 2023 and is anticipated to reach US$ 358.9 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030. North American market for Clindamycin Phosphate Topical is estimated to increase from $ million in 2023 to...


Global Doxercalciferol Market Research Report 2024

  • Jan 18, 24
  • ID: 3144
  • Pages: 81
  • Figures: 178
  • Views: 20
  • From $2,900

Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease. It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion. The global Doxercalciferol market was valued at US$ 354 million in 2023 and is anticipated to reach US$ 521.7 million by 2030, witnessing a CAGR of 5.8% du...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232